Acambis

Biotechnology company developing vaccines to treat infectious diseases in europe and north america.

Launch date

1992

Employees

Market cap

Enterprise valuation

AUD563m (Public information from Jul 2008)

Company register number 02863682

Cambridge England (HQ)

Revenues, earnings & profits over time

EUR	2015	2016	2017
Profit	101m	<1m	<1m

Date	Investors	Amount	Round
Jul 2008	Sanofi Pasteur	£276m Valuation: £276m	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Financials